Advertisement
Advertisement
U.S. markets open in 4 hours 10 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Metacrine, Inc. (MTCR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.5400+0.0600 (+1.72%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close3.4800
Open3.4700
Bid0.0000 x 1400
Ask0.0000 x 1000
Day's Range3.4002 - 3.5650
52 Week Range2.5900 - 11.0000
Volume130,726
Avg. Volume222,731
Market Cap93.901M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.3660
Earnings DateNov 10, 2021 - Nov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MTCR

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Metacrine, Inc.
    Daily – Vickers Top Buyers & Sellers for 01/29/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    9 months agoArgus Research
View more
  • Benzinga

    48 Biggest Movers From Friday

    Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares climbed 58% to close at $5.45 on Friday. Clearwater Analytics Holdings, Inc. (NYSE: CWAN) surged 40.9% to settle at $25.37 after the company priced its IPO at $18 per share. Unique Fabricating, Inc. (NASDAQ: UFAB) gained 36.9% to close at $3.45. Form 4 filings from late Thursday showed stock purchases from multiple company’s Directors. Paltalk, Inc. (NASDAQ: PALT) climbed 35.5% to settle at $4.01. Paltalk, last month, reported Q2 earnings of $0

  • GlobeNewswire

    Metacrine Achieves Full Enrollment for MET642 Phase 2a Trial in Patients With Nash

    Exceeded enrollment target of 180 total patientsInterim data from the first 60 patients expected early in the fourth quarter of 2021Topline MET642 trial results from all patients are anticipated in the first half of 2022 SAN DIEGO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced that it has completed enrollment for its Phase 2a tr

  • GlobeNewswire

    Metacrine to Host Virtual R&D Day for Analysts and Investors on September 15, 2021

    Featuring KOL and management discussions on the science of FXR agonists and the Company’s programs in NASH and IBD SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced it will host a virtual R&D Day for analysts and investors on Wednesday, September 15, 2021 at 12:00 p.m. ET. The event will showcase Metacrine’s programs in n

Advertisement
Advertisement